Komipharm International Co. Ltd (041960) — Capital Reinvestment Ratio
Komipharm International Co. Ltd (041960) has a Capital Reinvestment Ratio of 1.95x as of December 2025, meaning it reinvests 2% of its operating cash flow (₩946.94 Million) in capital expenditures (₩1.85 Billion). See 041960 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Komipharm International Co. Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Komipharm International Co. Ltd's Capital Reinvestment Ratio across 6 annual periods. Check 041960 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Komipharm International Co. Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Komipharm International Co. Ltd from 2013 to 2024. For live market cap and broader valuation context, see 041960 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.45x | ₩8.85 Billion | ₩3.98 Billion | ▼ -99.3% |
| 2020 | 65.70x | ₩25.20 Million | ₩1.66 Billion | ▲ +988.4% |
| 2019 | 6.04x | ₩950.79 Million | ₩5.74 Billion | ▼ -46.9% |
| 2017 | 11.37x | ₩235.64 Million | ₩2.68 Billion | ▲ +12.3% |
| 2016 | 10.13x | ₩1.21 Billion | ₩12.24 Billion | ▲ +59.8% |
| 2013 | 6.34x | ₩3.93 Billion | ₩24.93 Billion | — |